2BB score and signals
Eton Pharmaceuticals, Inc.’s current 2BB score is 42 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 67 | High |
| Momentum | 57 | Stable |
| Financial strength | 62 | Strong |
| Quality | 60 | Strong |
| Risk | 57 | Moderate |
Company facts
| Founded | 2017 |
| Employees | 44 |
| 52-week range | $14.27 – $50.18 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | 0.329 | — | $39.64M |
| 2026-08-13 | — | 0.1173 | — | $27.66M |
| 2026-05-14 | 0.05 | 0.0918 | $24.27M | $22.76M |
| 2026-03-19 | 0.06 | 0.0918 | $21.28M | $20.99M |
Related companies
